Status:

RECRUITING

Carotid Intraplaque Neovascularization Combined With Stress Echo

Lead Sponsor:

Dr. Amer Johri

Collaborating Sponsors:

Lantheus Medical Imaging

Conditions:

Atherosclerosis

Cardiovascular Diseases

Eligibility:

All Genders

18+ years

Brief Summary

The root cause of heart attacks and strokes is atherosclerosis, the hardening and thickening of blood vessels due to the presence of "plaque" which is a build-up of fat and cholesterol in the walls of...

Detailed Description

Primary Aim: To determine if carotid intraplaque neovascularization score (IPN) combined with stress echo (SE) \[IPN+SE\] enhances prediction of 3-year major adverse cardiovascular events (MACE) compa...

Eligibility Criteria

Inclusion

  • Men and women \>18 years;
  • Referred for a clinically indicated SE for assessment of ischemia and risk stratification;
  • Able and willing to give informed consent.

Exclusion

  • Emergency procedure, or active acute coronary syndrome (active chest pain, ischemic electrocardiogram changes, or cardiac enzyme elevation);
  • Referral for viability, pulmonary hypertension, or valve assessment;
  • Referral outside of the normal working hours;
  • History of significant CAD: percutaneous coronary intervention (PCI), coronary artery bypass graft (GABG), or coronary angioplasty;
  • History of stroke or myocardial infarction (MI);
  • Known or documented hypersensitivity or allergy to perflutren (DEFINITY® contrast agent);
  • Known or documented allergy to Polyethylene Glycol (Peg) a component of DEFINITY®;
  • History of carotid surgery (endarterectomy or stenting);
  • Any serious medical condition or complication from the stress test that according to the investigator could interfere with the carotid scan or optimal care;
  • Currently pregnant or breastfeeding;
  • Previous enrolment into the study.

Key Trial Info

Start Date :

August 16 2021

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

August 16 2026

Estimated Enrollment :

1500 Patients enrolled

Trial Details

Trial ID

NCT05416385

Start Date

August 16 2021

End Date

August 16 2026

Last Update

February 6 2025

Active Locations (6)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (6 locations)

1

University of Calgary

Calgary, Alberta, Canada, T2N 1N4

2

University of Alberta

Edmonton, Alberta, Canada, T6G 2R3

3

Dalhousie University

Halifax, Nova Scotia, Canada, B3H 3A7

4

The Kingston Heart Clinic

Kingston, Ontario, Canada, K7L 1C2